How one woman's frustration with prenatal vitamins led to a $250M supplement company
By
Renée Onque, Lauren Shamo
Summary
Katerina Markov Schneider, pregnant in 2015, was dissatisfied with the prenatal vitamins on the market due to heavy metals and artificial ingredients. She quit her job as a venture partner to found Ritual, a supplement company focused on transparency and clean ingredients. The company has since grown to generate $250 million in annual revenue, built on a mission to set a new standard in the supplement industry.
Source
bskyHow one woman's frustration with prenatal vitamins led to a $250M supplement companycnbc.comKey quotes
· 2 pulledI knew we all deserved better, including myself.
And this passion to set a new standard in this supplement industry took over.
You might also wanna read
High-Dose Vitamin D3 During Pregnancy Shows No Cognitive Benefit for Children at Age 10: Secondary Analysis of RCT
This post hoc secondary analysis of a randomized clinical trial investigates whether high-dose vitamin D3 supplementation during pregnancy (
jamanetwork.com·27d ago
Multivitamins: The evidence is more positive than doctors often suggest
The article examines the debate around multivitamin supplements, noting that while many doctors dismiss them as producing "expensive urine"
economist.com·9d ago
Suplementos vs. alimentos reales: cuál conviene y de qué depende, según la evidencia
Satirical piece uses smoking to critique misleading supplement claims
This article uses a clickbait-style hook to reveal a satirical point about performance supplements. It claims to have found a "miracle suppl
thegrowtheq.com·13d ago
Kenvue Stock Drops 10% on Report Linking Tylenol Use During Pregnancy to Autism
Kenvue's stock dropped over 10% following a Wall Street Journal report that HHS Secretary Robert F. Kennedy Jr. will likely release a report
cnbc.com·10mo ago
Are multivitamin pills worth taking? The evidence is more nuanced than doctors suggest
The article examines the debate around multivitamin supplements, noting that while many doctors dismiss them as producing "expensive urine"
economist.com·6d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.